A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
News-Medical.Net on MSN
New global guidelines improve reporting of pediatric randomized controlled trials
Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...
Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...
An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and ...
What if stumbling upon a product makes you love it more? Science says this is true. And the reason why reveals something ...
2don MSN
A New Study of More Than 8,000 People Found That This One Supplement Firms And Hydrates Aging Skin
Dermatologists are celebrating.
A new research paper was published in Volume 18 of Aging-US on February 6, 2026, titled "Causal effects of inflammation on long-term mortality: a Mendelian randomization study." ...
The trials are evaluating DURAVYU (vorolanib intravitreal insert) for the treatment of diabetic macular edema (DME).
This week Mad in America examines three studies around art therapy and art-based interventions for mental health issues. Two studies reported on the lived Studies find art-based interventions can be ...
Active Phase 3 programs for DURAVYU in wet AMD and DME, the two largest multi-billion-dollar retinal disease markets - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results